
AVITA Medical RCEL
$ 3.72
-3.26%
Annual report 2025
added 02-12-2026
AVITA Medical Cash Conversion Cycle 2011-2026 | RCEL
Annual Cash Conversion Cycle AVITA Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 256 | 313 | 222 | 164 | 380 | -332 | 223 | 2.29 K | 674 | 580 | -19.1 | 532 | 44.3 | 47.8 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.29 K | -332 | 384 |
Quarterly Cash Conversion Cycle AVITA Medical
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 280 | 311 | - | 229 | 347 | 446 | - | 199 | 161 | 170 | - | 156 | 166 | 141 | - | 191 | 104 | 112 | 258 | 177 | 162 | 74 | - | 74.4 | 93.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 446 | 74 | 193 |
Cash Conversion Cycle of other stocks in the Medical devices industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Allied Healthcare Products
AHPI
|
271 | - | 3.58 % | $ 2.21 M | ||
|
Apollo Endosurgery
APEN
|
156 | - | - | $ 475 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
104 | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
299 | - | - | $ 3.31 B | ||
|
Acutus Medical
AFIB
|
761 | - | -26.83 % | $ 2.62 M | ||
|
Lianluo Smart Limited
LLIT
|
94.1 | - | 24.59 % | $ 44.8 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
174 | - | -5.86 % | $ 30.6 M | ||
|
Aziyo Biologics
AZYO
|
111 | - | 1.37 % | $ 20.5 M | ||
|
Apyx Medical Corporation
APYX
|
246 | $ 3.88 | -1.02 % | $ 134 M | ||
|
Cognyte Software Ltd.
CGNT
|
-4.41 | $ 6.9 | -4.17 % | $ 495 M | ||
|
Alphatec Holdings
ATEC
|
251 | $ 13.17 | -2.23 % | $ 1.88 B | ||
|
BIOLASE
BIOL
|
129 | - | -13.19 % | $ 166 K | ||
|
Bio-Rad Laboratories
BIO
|
263 | $ 292.08 | -0.55 % | $ 8.24 B | ||
|
Conformis
CFMS
|
165 | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
227 | $ 36.61 | -13.72 % | $ 5.46 K | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
CONMED Corporation
CNMD
|
218 | $ 41.57 | -1.8 % | $ 1.28 B | ||
|
Boston Scientific Corporation
BSX
|
118 | $ 74.23 | 1.03 % | $ 109 B | ||
|
Abbott Laboratories
ABT
|
100 | $ 112.24 | -1.19 % | $ 195 B | ||
|
Cardiovascular Systems
CSII
|
172 | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
404 | - | -10.19 % | $ 1.99 M | ||
|
CryoLife, Inc.
CRY
|
183 | - | -4.14 % | $ 702 M | ||
|
ClearPoint Neuro
CLPT
|
240 | $ 13.0 | -2.8 % | $ 351 M | ||
|
EDAP TMS S.A.
EDAP
|
163 | $ 4.82 | -1.73 % | $ 180 M | ||
|
Soliton, Inc.
SOLY
|
-67.9 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-227 | - | 0.03 % | $ 1.58 B | ||
|
Dynatronics Corporation
DYNT
|
80.5 | - | 14.99 % | $ 929 K | ||
|
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
81.2 | - | - | $ 111 M | ||
|
Electromed
ELMD
|
180 | $ 23.39 | -7.4 % | $ 198 M | ||
|
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | ||
|
Eargo
EAR
|
32.7 | - | - | $ 10.2 M | ||
|
InMode Ltd.
INMD
|
180 | $ 14.36 | 0.81 % | $ 1.14 B | ||
|
GBS
GBS
|
204 | - | -0.57 % | $ 7.12 M | ||
|
Second Sight Medical Products
EYES
|
-21 | - | -0.97 % | $ 54.4 M | ||
|
Avinger
AVGR
|
335 | - | -20.74 % | $ 369 K | ||
|
FONAR Corporation
FONR
|
234 | $ 18.54 | -0.22 % | $ 122 M | ||
|
Globus Medical
GMED
|
319 | $ 87.0 | -1.43 % | $ 11.8 B | ||
|
IRadimed Corporation
IRMD
|
267 | $ 99.45 | -3.52 % | $ 1.26 B | ||
|
Integer Holdings Corporation
ITGR
|
87.9 | $ 84.9 | -2.62 % | $ 2.85 B | ||
|
Myomo
MYO
|
32.2 | $ 0.8 | 0.29 % | $ 5.64 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
222 | $ 10.88 | -2.68 % | $ 838 M | ||
|
Establishment Labs Holdings
ESTA
|
355 | $ 72.93 | 0.29 % | $ 2.05 B | ||
|
IRIDEX Corporation
IRIX
|
119 | $ 1.35 | -5.59 % | $ 21.8 M | ||
|
Invacare Corporation
IVC
|
214 | - | - | $ 24.7 M | ||
|
Cytosorbents Corporation
CTSO
|
50.6 | $ 0.63 | 1.76 % | $ 34.3 M | ||
|
Pulmonx Corporation
LUNG
|
292 | $ 1.44 | -1.03 % | $ 56.3 M | ||
|
OrthoPediatrics Corp.
KIDS
|
723 | $ 16.62 | -3.48 % | $ 384 M |